Back to search

Article

Predicting vaccine effectiveness in Mpox

2023-11-24

Abstract excerpt

The Modified Vaccinia Ankara vaccine developed by Bavarian Nordic (MVA-BN) was widely deployed to prevent Mpox during the 2022 global outbreak. This vaccine was initially approved for Mpox based on its reported immunogenicity and effectiveness in animal models, rather than evidence of clinical efficacy. However no validated correlate of protection after vaccination has been identified. Here we performed a systemat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ba7752f-c9cb-5f4e-97f3-df71fa15fc01
DOI
10.1101/2023.11.23.23298850
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting vaccine effectiveness in MpoxDOI 10.1101/2023.11.23.23298850
Select a neighboring publication to make it the new centre.